gene therapy
gene therapy is a genetic therapy with 19 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
13
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
3
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Study of Chemogenetic Gene Therapy With AAV Virus for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
A Phase I Study of CREPT-618 in Locally Advanced HCC
A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease
A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy
Gene Therapy for IGHMBP2-Related Diseases
Clinical Trials (19)
Clinical Study of Chemogenetic Gene Therapy With AAV Virus for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
A Phase I Study of CREPT-618 in Locally Advanced HCC
A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease
A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy
Gene Therapy for IGHMBP2-Related Diseases
A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease
Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID
Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A
ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID
Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy
An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
The World Federation of Hemophilia Gene Therapy Registry
Gene Therapy in Treating Patients With Primary Brain Tumors
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Gene Therapy for Gyrate Atrophy
Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
All 19 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 19